ADBiotech Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 18, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	31,645	19,012	29,935	30,712	45,092	37,494
Market Cap Growth	76.19%	-36.49%	-2.53%	-31.89%	20.26%	-
Enterprise Value	31,160	27,330	39,459	35,183	-	-
Last Close Price	1608.00	2080.00	3275.00	3360.00	9100.00	7566.67
PE Ratio	-	-	-	11.39	-	-
PS Ratio	2.17	1.71	2.86	2.89	3.81	3.82
PB Ratio	17.15	3.99	2.38	1.90	8.83	4.02
P/TBV Ratio	17.92	5.88	2.66	1.90	8.84	4.03
P/FCF Ratio	-	-	398.99	-	-	-
P/OCF Ratio	-	-	95.05	-	-	-
EV/Sales Ratio	2.14	2.45	3.77	3.31	-	-
EV/FCF Ratio	-12.84	-	525.92	-	-	-
Debt / Equity Ratio	4.17	2.46	1.08	0.79	2.58	0.78
Debt / FCF Ratio	-	-	181.40	-	-	-
Net Debt / Equity Ratio	-0.29	2.11	0.33	0.26	2.04	0.47
Net Debt / EBITDA Ratio	0.15	-3.25	-1.15	-0.97	-11.50	-5.39
Net Debt / FCF Ratio	0.22	-2.34	55.93	-0.44	-1.81	-0.70
Asset Turnover	0.59	0.44	0.35	0.41	0.60	-
Inventory Turnover	3.74	3.07	2.78	2.97	3.52	-
Quick Ratio	0.45	0.35	0.98	0.89	0.50	0.90
Current Ratio	0.68	0.62	1.19	1.20	0.69	1.32
Return on Equity (ROE)	-444.50%	-103.66%	-37.78%	25.33%	-36.92%	-
Return on Assets (ROA)	-11.65%	-10.06%	-10.09%	-11.98%	-4.88%	-
Return on Capital Employed (ROCE)	-80.10%	-43.00%	-28.40%	-25.90%	-18.70%	-7.50%
Earnings Yield	-34.81%	-41.83%	-9.57%	8.78%	-5.91%	-19.59%
FCF Yield	-7.67%	-22.54%	0.25%	-30.34%	-12.74%	-16.83%
Buyback Yield / Dilution	-17.13%	-	9.33%	-31.17%	-53.77%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.